CN101816723B - Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof - Google Patents
Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof Download PDFInfo
- Publication number
- CN101816723B CN101816723B CN2010101773390A CN201010177339A CN101816723B CN 101816723 B CN101816723 B CN 101816723B CN 2010101773390 A CN2010101773390 A CN 2010101773390A CN 201010177339 A CN201010177339 A CN 201010177339A CN 101816723 B CN101816723 B CN 101816723B
- Authority
- CN
- China
- Prior art keywords
- liver
- soboring
- protecting
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title abstract description 34
- 210000004185 liver Anatomy 0.000 title abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000002904 solvent Substances 0.000 claims abstract description 15
- 230000006837 decompression Effects 0.000 claims abstract description 14
- 239000003495 polar organic solvent Substances 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims description 111
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 83
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 241000628997 Flos Species 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 28
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 27
- 239000006187 pill Substances 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 22
- 239000012567 medical material Substances 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- 239000006196 drop Substances 0.000 claims description 14
- 238000011084 recovery Methods 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 239000003826 tablet Substances 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 12
- 239000003094 microcapsule Substances 0.000 claims description 12
- 239000006188 syrup Substances 0.000 claims description 12
- 235000020357 syrup Nutrition 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000004108 freeze drying Methods 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 39
- 208000007848 Alcoholism Diseases 0.000 abstract description 24
- 201000007930 alcohol dependence Diseases 0.000 abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- 231100000753 hepatic injury Toxicity 0.000 abstract description 13
- 230000001476 alcoholic effect Effects 0.000 abstract description 10
- 206010067125 Liver injury Diseases 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract 4
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 4
- 241000207199 Citrus Species 0.000 abstract 2
- 244000111489 Gardenia augusta Species 0.000 abstract 2
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 2
- 244000248825 Peltandra virginica Species 0.000 abstract 2
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 2
- 244000202052 Poncirus trifoliata Species 0.000 abstract 2
- 235000000404 Poncirus trifoliata Nutrition 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 235000020971 citrus fruits Nutrition 0.000 abstract 2
- 229940010454 licorice Drugs 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 28
- 230000035622 drinking Effects 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 20
- 239000000463 material Substances 0.000 description 20
- 229930003944 flavone Natural products 0.000 description 15
- 235000011949 flavones Nutrition 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 229930013930 alkaloid Natural products 0.000 description 14
- 229930182490 saponin Natural products 0.000 description 14
- 150000007949 saponins Chemical class 0.000 description 14
- 235000017709 saponins Nutrition 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000001154 acute effect Effects 0.000 description 10
- 230000000857 drug effect Effects 0.000 description 10
- 241000157835 Gardenia Species 0.000 description 9
- 150000002213 flavones Chemical class 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000003285 pharmacodynamic effect Effects 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 6
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 150000002212 flavone derivatives Chemical class 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 4
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000035508 accumulation Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 2
- 206010003084 Areflexia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 2
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 2
- 208000002353 alcoholic hepatitis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000271566 Aves Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100489867 Mus musculus Got2 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000208 hepatic perisinusoidal cell Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- -1 lipid aldehyde Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000008843 wulingsan Substances 0.000 description 1
- 239000008783 wuzi yanzong Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a sobering up and liver protecting Chinese medicinal preparation and a preparation method thereof. The Chinese medicinal preparation comprises the following components in percentage by weight: 6 to 50 percent of kudzu vine flower, 6 to 40 percent of trifoliate orange seed, 1 to 18 percent of gynostemma pentaphylla, 1 to 18 percent of Citrus seed, 1 to 18 percent of licorice, 1 to 18 percent of cape jasmine, 3 to 18 percent of kudzu vine root and 3 to 18 percent of tuckahoe. The preparation method comprises the following steps of: crushing the kudzu vine flower, the trifoliate orange seed, the gynostemma pentaphylla, the Citrus seed, the licorice and the cape jasmine into coarse powder; adding water solution of polar organic solvent in the powder for extracting; merging the extract; filtering and performing decompression recovering on the solvent; and concentrating to obtain sobering up and liver protecting Chinese medicinal extractum, and adding the kudzu vine root and the tuckahoe into the extractum to obtain a sobering up and liver protecting Chinese medicinal compound. The purpose of the method is to prepare the sobering up and liver protecting Chinese medicinal preparation safely, simply, reasonably and economically. The product has the advantages of relieving alcoholism, preventing drunkenness and preventing alcoholic liver injury, along with convenient taking, obvious curative effect, no toxic and side effect and the like and is particularly suitable for people who drink for a long time.
Description
Technical field:
The present invention relates to a kind of Green Chemistry method for preparing of from plant, extracting medicinal active ingredient, more specifically relate to a kind of Chinese medicine Soboring-up liver-protecting medicament and preparation method thereof.
Background technology:
Human body is a kind of normal physiological phenomenon to the catabolism of ethanol, and a spot of ethanol can become acetic acid by catabolism in the body under the effect of alcoholdehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), becomes CO through oxidation conversion more at last
2And H
2O excretes, but excess ethanol is easy to change into free radical because the branch of metabolism is in time taken off, and causes a series of body functions disorderly, and the alcoholism symptom takes place.
Big quantity research shows; Fat-storing cell activation after drinking for a long time plays main effect to alcoholic liver damage (ALD); And the oxidation of ethanol and acetaldehyde can promote oxygen production; Make MDA increase in the liver, the lipid aldehyde of MDA by product plays facilitation to hepatic injury.Alcoholic liver damage comprises early lesion alcoholic fatty liver (AFL) hepatic fibrosis (LF), alcoholic hepatitis (AH), liver cirrhosis sick types such as (LC).
In the mechanism of alcoholic liver damage, the direct detrimental effect of ethanol is main, and nutritional disorder only is a secondary cause.Can affirm that long-term excess intake ethanol and lipometabolic degeneration change the regulating liver-QI sclerosis has close ties, the certain protection effect is played in the accumulation of content of triglyceride in the liver thereby free radical scavenger can slow down effectively.If aldehyde dehydrogenase (ALDH) lacks then a large amount of acetaldehyde accumulations, cause the generation of mitochondrion obstacle and acetaldehyde-memebrane protein chemical compound, thereby cause alcoholic liver damage.
Alcoholism has become a worldwide problem; List in one of cardiovascular and cerebrovascular disease, cancer three the most serious public health problems afterwards abroad; Countries in the world all are devoted to study crapulent pathogeny and are removed mechanism; And seek the effective method of alcoholism control on unremitting effort ground, its key is to delay alcoholic acid absorption and promotes its catabolism in vivo, improves the physiological function of liver and the drainage of accelerating alcohol and metabolite thereof.
In state-owned abundant resources of medicinal plant; Also there are many relieve the effect of alcohol good recipe and the secret recipe that relieves the effect of alcohol in successive dynasties; How to adopt modern separation technology, excavate the Traditional Chinese Medicine precious deposits, carry out in a deep going way to have relieve the effect of alcohol, the research and development of the health product of anti-intoxication and liver-protecting function have theory and realistic meaning.
American-European countries generally is to adopt method emetic or that the transfusion ion replenishes to delay the ethanol absorption in vivo to alcoholism; Then give the S-adenyl residue to alcoholic liver damage; L-methionine (SAME) or unsaturated lecithin; Utilize that SAME changes in vivo that glutathion improves that radical scavenging activity or unsaturated lecithin had into to strengthen the collagen fiber catabolic enzyme active, prevent the function of hepatic fibrosis; Then adopt Allylnoroxymorphone to utilize it to remove β-Nei calf to acute alcoholism and bark to maincenter, the inhibitory action of N system improves symptom.
The Japan scholar studies to alcoholic liver injury and aspects such as pathogenesis and alcohol metabolism approach thereof; Its Therapeutic Method is generally continued to use the Chinese medicine with antialcoholism function or the prescription of Chinese prescription record; As adopt WULING SAN to prevent alcoholic liver injury and the metabolism disorder of ethanol property thereof; Adopt the Developmental and Metabolic Disorder and the hepatic injury of Flos puerariae lobatae separator treatment alcohol-induced, adopt Semen Hoveniae extract (Fructus Hoveniae extract) and adopt Radix Et Caulis Acanthopanacis Senticosi or Radix Ginseng extract control alcoholism.And listing of existing multiple product as the liquor-saturated celestial being of peace relieve the effect of alcohol ball (Japanese SS PHARMACEUTICAL CO (JP) produces) and Solumark (Japanese Taiho Pharmaceutical Co. Ltd produces) are in Japan, Southeast Asia and the situation of selling well of area, Hong Kong, Macao and Taiwan.
Ancient Times in China has many good recipes of relieving the effect of alcohol all through the ages, and the various diseases that cause drinking all have corresponding prescription.Contained according to ancient books; Prescription or method of treatment are varied, only to the intact statistics of Holy Benevolent Prescriptions, Effective Formulas Tested by Physicians for Generations, " Prescriptions for Universal Relief " and " hospital birdss of the same feather flock together ", size relieve the effect of alcohol with alleviating alcohol addiction side's medicine about 150 surplus kind; The prescription that wherein relieves the effect of alcohol accounts for 90%, and the alleviating alcohol addiction prescription accounts for 10%.The ability of relieving the effect of alcohol that current China has the part scholar that wherein quintessence of Chinese culture ancient prescription such as Flos puerariae lobatae are separated the proved recipes that relieve the effect of alcohol such as the soup of sobering up, winebibber's pleasure, dried clock wine, Shigao Tang and WUZIYANZONG WAN is studied; And there is the people to develop sober-up oral liquid, drunkenness dispelling tea and antialcoholism function preparation; The Chinese medicine that relieves the effect of alcohol is being carried out pharmacology; Find in pharmacodynamics and the clinical research that Chinese medicine such as Radix Puerariae, Semen Hoveniae (Fructus Hoveniae), Radix Glycyrrhizae or preparation have the stronger effect of relieving the effect of alcohol and reducing the concentration of ethanol in blood.
Because Chinese crude drug complex chemical composition; The extract of the extraction process by water preparation that Chinese medicine adopted; Though contain the main medicinal active component of Soboring-up liver-protecting such as flavone, saponin, alkaloid; But also there are inactive impurity compositions such as amounts of protein, polysaccharide, quintessence oil, tannin, vitamin, inorganic salt and organic acid to exist; Defectives such as product obviously exists easy moisture absorption, preservation difficulty, flavone, saponin, alkaloid isoreactivity composition purity is not high, the Soboring-up liver-protecting content of drug effect components is lower, the quality of product, scientific and technological gold content, added value are all not high.
The extract of the aqueous extraction-alcohol precipitation technology preparation that Chinese medicine adopted; Though help the raising of flavone, saponin, alkaloid isoreactivity composition purity; But the selectivity of aqueous extraction-alcohol precipitation technology is relatively poor, when removing protein, polysaccharide and other biomacromolecule solid content impurity, has usually lost the medicinal active component of Soboring-up liver-protecting of part; Yield and drug effect that this will badly influence Chinese medicine Soboring-up liver-protecting medicament cause the preparation cost of product high.
Summary of the invention:
The objective of the invention is to overcome the deficiency of traditional product and technology; Provide a kind of low cost, high yield, high-quality, be suitable for industrial Chinese medicine Soboring-up liver-protecting medicament and preparation method thereof; Can prepare Chinese medicine Soboring-up liver-protecting medicament safe, easy, rationally, economically; Have taking convenience, evident in efficacy, advantage such as have no side effect, can reach relieve the effect of alcohol, anti-intoxication, the effect that prevents alcoholic liver injury, the crowd who is particularly suitable for drinking for a long time.
Chinese medicine Soboring-up liver-protecting medicament of the present invention is characterised in that: each composition weight proportioning is Flos puerariae lobatae 6～50%, Semen Hoveniae (Fructus Hoveniae) 6～40%, Herb Gynostemmae Pentaphylli 1～18%, Fructus Ponciri Trifoliatae 1～18%, Radix Glycyrrhizae 1～18%, Fructus Gardeniae 1～18%, Radix Puerariae 3～18%, Poria 3～18%.
Chinese medicine Soboring-up liver-protecting medicament of the present invention can be a Chinese medical concrete; Its preparation method is following: with Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae and Fructus Gardeniae pulverize separately to coarse powder; Add the polar organic solvent aqueous solution and extract, merge extractive liquid, filters; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete.
Chinese medicine Soboring-up liver-protecting medicament of the present invention can be the Chinese medicine complex also, and its preparation method is following: Radix Puerariae, Poria pulverize separately are become fine powder, add mixing in the above-mentioned Chinese medical concrete, drying is processed Soboring-up liver-protecting Chinese medicine complex.
The drying mode of above-mentioned preparation Chinese medicine complex can be spray drying, lyophilization, pneumatic conveying drying, microwave drying or vacuum drying.
Above-mentioned polar organic solvent can be one or more mixed solvents in methanol, ethanol or the acetone, preferentially selects methanol or acetone for use.
Remarkable advantage of the present invention is: adopt the polar organic solvent extraction with aqueous solution to be the Chinese medical concrete of main medicinal active ingredient and Chinese medicine complex with flavone, saponin, alkaloid etc.; And then preparation Chinese medicine Soboring-up liver-protecting medicament; Can not only greatly improve the yield and the quality of product; Significantly reduce the preparation cost of product, and have tangible novelty.
The specific embodiment:
The weight proportion of each component of Chinese medicine Soboring-up liver-protecting medicament embodiment of the present invention is: Flos puerariae lobatae 25～40%, Semen Hoveniae (Fructus Hoveniae) 15～30%, Herb Gynostemmae Pentaphylli 3～10%, Fructus Ponciri Trifoliatae 3～10%, Radix Glycyrrhizae 3～10%, Fructus Gardeniae 3～10%, Radix Puerariae 6～10%, Poria 6～10%.
The method for preparing of Chinese medical concrete of the present invention is following: with Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae and Fructus Gardeniae pulverize separately to coarse powder; The final concentration that adopts 9～15 times of medical material amounts (W/W) is 30%～70% polar organic solvent aqueous solution, under 50 ℃～80 ℃ conditions, extracts 1～3 time each 1～3 hour; Merge extractive liquid; Filter, decompression and solvent recovery, vacuum concentration becomes Chinese medical concrete.
The method for preparing of Chinese medicine complex of the present invention is following: Radix Puerariae, Poria pulverize separately are become fine powder, add mixing in the above-mentioned Chinese medical concrete, drying is processed Soboring-up liver-protecting Chinese medicine complex.
The drying mode of above-mentioned preparation Chinese medicine complex can be spray drying, lyophilization, pneumatic conveying drying, microwave drying or vacuum drying.
Above-mentioned polar organic solvent can be one or more mixed solvents in methanol, ethanol or the acetone, preferentially selects methanol or acetone for use.Mainly the extraction effect based on methanol, ethanol or acetone three is suitable for this, but relative ethanol, the boiling point of methanol or acetone is lower, energy consumption is littler, can significantly reduce the preparation cost of product.
Above-mentioned Chinese medical concrete or Chinese medicine complex can be made into the oral Soboring-up liver-protecting preparation that is suitable for clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill.
Below further set forth part embodiment of the present invention, be intended to describe in detail method for preparing of the present invention, but be not limited thereto.
Embodiment 1
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes; Get material according to prescription (Flos puerariae lobatae 25%, Semen Hoveniae (Fructus Hoveniae) 30%, Herb Gynostemmae Pentaphylli 10%, Fructus Ponciri Trifoliatae 6%, Radix Glycyrrhizae 10%, Fructus Gardeniae 3%), add 70% ethanol water of 15 times of medical material amounts (W/W), lixiviate is 1 hour under 80 ℃ of conditions; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 10.7%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, promptly got Soboring-up liver-protecting Chinese medicine complex after spray-dried according to prescription (Radix Puerariae 10%, Poria 6%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 3.6% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 32.2%, total saponins 13.5%, total alkaloids 8.9%.
Embodiment 2
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 25%, Semen Hoveniae (Fructus Hoveniae) 30%, Herb Gynostemmae Pentaphylli 3%, Fructus Ponciri Trifoliatae 7%, Radix Glycyrrhizae 8%, Fructus Gardeniae 8%), add 60% ethanol water of 13 times of medical material amounts (W/W); Lixiviate is 2 times under 65 ℃ of conditions, and each 2 hours, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 10.6%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, after lyophilization, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 10%, Poria 6%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 6.2% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 31.4%, total saponins 15.1%, total alkaloids 9.1%.
Embodiment 3
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 25%, Semen Hoveniae (Fructus Hoveniae) 30%, Herb Gynostemmae Pentaphylli 6%, Fructus Ponciri Trifoliatae 10%, Radix Glycyrrhizae 3%, Fructus Gardeniae 10%), add 30% ethanol water of 9 times of medical material amounts (W/W); Lixiviate is got 3 times under 50 ℃ of conditions, and each 3 hours, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 11.8%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, behind vacuum drying, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 10%, Poria 6%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 5.0% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 33.5%, total saponins 13.8%, total alkaloids 10.1%.
Embodiment 4
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 30%, Semen Hoveniae (Fructus Hoveniae) 25%, Herb Gynostemmae Pentaphylli 10%, Fructus Ponciri Trifoliatae 3%, Radix Glycyrrhizae 6%, Fructus Gardeniae 10%), add 40% methanol aqueous solution of 9 times of medical material amounts (W/W); Lixiviate is got 3 times under 60 ℃ of conditions, and each 2 hours, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 10.3%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, after lyophilization, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 6%, Poria 9%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 6.7% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 33.1%, total saponins 14.5%, total alkaloids 9.4%.
Embodiment 5
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 30%, Semen Hoveniae (Fructus Hoveniae) 25%, Herb Gynostemmae Pentaphylli 3%, Fructus Ponciri Trifoliatae 10%, Radix Glycyrrhizae 10%, Fructus Gardeniae 6%), add 30% methanol aqueous solution of 15 times of medical material amounts (W/W); Lixiviate is got 2 times under 50 ℃ of conditions, and each 3 hours, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 11.9%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, behind vacuum drying, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 6%, Poria 9%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 5.2% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 32.9%, total saponins 15.1%, total alkaloids 8.7%.
Embodiment 6
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes; Get material according to prescription (Flos puerariae lobatae 30%, Semen Hoveniae (Fructus Hoveniae) 25%, Herb Gynostemmae Pentaphylli 8%, Fructus Ponciri Trifoliatae 5%, Radix Glycyrrhizae 6%, Fructus Gardeniae 10%), adds 70% methanol aqueous solution of 12 times of medical material amounts (W/W), in 80 ℃ of condition refluxed extractions 1 hour; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 10.8%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, promptly got Soboring-up liver-protecting Chinese medicine complex after spray-dried according to prescription (Radix Puerariae 6%, Poria 9%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 4.1% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 33.1%, total saponins 14.2%, total alkaloids 10.2%.
Embodiment 7
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 40%, Semen Hoveniae (Fructus Hoveniae) 15%, Herb Gynostemmae Pentaphylli 7%, Fructus Ponciri Trifoliatae 6%, Radix Glycyrrhizae 10%, Fructus Gardeniae 6%), add 30% aqueous acetone solution of 14 times of medical material amounts (W/W); Lixiviate is got 3 times under 50 ℃ of conditions, and each 3 hours, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 12.1%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, behind vacuum drying, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 5%, Poria 10%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 5.6% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 31.8%, total saponins 12.7%, total alkaloids 9.2%.
Embodiment 8
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 40%, Semen Hoveniae (Fructus Hoveniae) 15%, Herb Gynostemmae Pentaphylli 10%, Fructus Ponciri Trifoliatae 7%, Radix Glycyrrhizae 3%, Fructus Gardeniae 9%), add 70% aqueous acetone solution of 9 times of medical material amounts (W/W); Extract 2 times in 80 ℃ of condition refluxed, each 1 hour, merge extractive liquid; Filter; Decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete, and experiment shows that extraction ratio is 10.5%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, promptly got Soboring-up liver-protecting Chinese medicine complex after spray-dried according to prescription (Radix Puerariae 5%, Poria 10%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 4.3% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 33.8%, total saponins 15.9%, total alkaloids 9.3%.
Embodiment 9
With medical material pulverize separately to 16～30 purpose coarse powder such as Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae, Fructus Gardeniaes, get material according to prescription (Flos puerariae lobatae 40%, Semen Hoveniae (Fructus Hoveniae) 15%, Herb Gynostemmae Pentaphylli 9%, Fructus Ponciri Trifoliatae 6%, Radix Glycyrrhizae 8%, Fructus Gardeniae 6%), add 50% aqueous acetone solution of 15 times of medical material amounts (W/W); Extracted 2 hours in 70 ℃ of condition refluxed; Merge extractive liquid, filters decompression and solvent recovery; Be condensed into the Soboring-up liver-protecting Chinese medical concrete, experiment shows that extraction ratio is 10.2%.
Radix Puerariae, Poria pulverize separately were become 100 purpose fine powders, got material, added mixing in the above-mentioned Chinese medical concrete, after lyophilization, promptly got Soboring-up liver-protecting Chinese medicine complex according to prescription (Radix Puerariae 5%, Poria 10%).
Formulation method according to routine; Above-mentioned Soboring-up liver-protecting Chinese medical concrete or Soboring-up liver-protecting Chinese medicine complex are processed any oral Soboring-up liver-protecting preparation applicatory clinically, as: capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill etc.Through measuring the water content 6.5% of Chinese medicine Soboring-up liver-protecting medicament, total flavones 32.7%, total saponins 12.9%, total alkaloids 8.8%.
The physical and chemical parameter assay method of each prepared product of the present invention is following:
(1) mensuration of general flavone content: adopting HPLC, is contrast with the Quercetin.Chromatographic condition: chromatographic column is selected Waters Nova-Pak C for use
18Post (Φ 3.9 * 15mm, 4 μ m), pre-column C
18(3.9mm * 15mm), mobile phase is methanol: 0.2% phosphate aqueous solution (45: 55), and flow velocity 1.0mL/min, 34 ℃ of column temperatures detect wavelength 365nm, sample size 20 μ L.The mensuration of sample: get liquid 4mL to be measured (or determinand powder 0.1g, be dissolved in the 4mL solvent), add methanol 6mL and 12mol/L hydrochloric acid 1mL, shake up rearmounted 80 ℃ of water-bath back hydrolysis 1h.Then hydrolyzed solution is changed in the 50mL volumetric flask, be diluted to scale, as HPLC liquid to be measured with 50% methanol.Adopting external standard method quantitative in the HPLC mensuration process, is contrast with the Quercetin, the content of each aglycon after the calculating hydrolysis, and the unified correction factor 2.51 that multiply by calculates general flavone content.
(2) mensuration of total alkaloid content: adopting the IKI colorimetry, is contrast with the nuciferine.Sample solution is diluted to certain multiple, gets 1mL in test tube, add 0.05mL5% Wagner's reagent solution, shake up, place 5min after, measure absorbance in the 400nm wavelength, with reagent as blank.
(3) mensuration of total saponin content: adopting vanillin-concentrated sulphuric acid colorimetry, is contrast with ginsenoside Re.Get the sample liquid 1ml that dilutes suitable multiple, add the 0.5ml vanillin, add the 2.5ml concentrated sulphuric acid again, behind the reaction 10min, measure absorbance down in the 580nm wavelength, with water as blank.
(4) water content adopts quick moisture test apparatus to measure.
The spray drying condition is: feeding liquid concentration 10～20 Baume degrees (60 ℃), 160～250 ℃ of spraying machine inlet temperatures, 60～110 ℃ of outlet temperatures, centrifugal head operating pressure 1.6～3.0kgf/cm2.
The lyophilization condition is: baking temperature-10～-60 ℃, 35～70 ℃ of sublimation temperatures, pressure 0.05～0.18mbar, drying time 20～40h.
The vacuum drying condition is: 45～75 ℃ of baking temperatures, pressure 0.01～0.095MPa, drying time 15～50h.
The relieving alcoholism and preventing drunkenness animal pharmacodynamics evaluation experimental of medicament of the present invention
1 experiment material
Kunming kind white mice, body weight 20 ± 2g, the male and female dual-purpose is available from rodent experimental center, Fujian Province.Soboring-up liver-protecting Chinese medical concrete, Soboring-up liver-protecting Chinese medicine complex, Soboring-up liver-protecting Chinese medicine preparation (self-control product, recommended intake are 2.4g solid content (dry weight)/person-time) are made into 0.12g/mL with normal saline during administration.Pacify the liquor-saturated celestial being ball tablet (commercially available, Japanese SS PHARMACEUTICAL CO (JP) product, recommended intake are 6g/ person-time) that relieves the effect of alcohol, be made into 0.3g/mL with normal saline during administration.55 degree strong, colourless liquor distilled from sorghum (commercially available, Beijing China all make wine Company products), distilled water diluting becomes 40 degree when giving wine.
2 experimental techniques
2.1 separate drunk pharmacodynamic experiment
3 batches of white mice through 5 days environmental adaptation after; Be divided into some groups at random; Male and female half and half are waited to try the mice overnight fasting (about 12～14h), are given wine with the heavy dosage of 40 degree wine 0.37mL/20g Mus next day for every group; Respectively with normal saline, Soboring-up liver-protecting Chinese medical concrete, Soboring-up liver-protecting Chinese medicine complex, Soboring-up liver-protecting Chinese medicine preparation and pacify the ball administration of relieving the effect of alcohol of liquor-saturated celestial being, dosage is 0.40mL/20g Mus heavy (promptly advise the human intaking amount 60 times) behind the 20min.
Drunk after drinking rate of first experimental evaluation acute alcoholism mice and tolerance time thereof with hold time: give promptly to be picked up counting after drinking; Write down the drunk number of white mice and righting reflex loss time and recovery time respectively, calculate drunk after drinking rate of mice and tolerance time thereof and hold time.
The second batch of experimental evaluation acute alcoholism mice ethanol in blood content and SOD enzyme are lived: pluck eyeball for after drinking 90min and get blood; With 0.3mL 3.8% citric acid three sodium solution anticoagulation, gas chromatography determination Mus BAC and pyrogallol autoxidation method are measured the SOD enzyme and are lived.
The 3rd batch of experimental evaluation chronic alcoholism mice alcoholic liver injury situation: after the continuous 28 days administration of process is tested to wine; Wait to try mice fasting 12h for every group; Dissect mice next day; Observe internal organs pathological changes situation, get liver and carry out measuring LPO content behind the LH, process liver slice and carry out electron microscopic observation hepatic tissue cell degenerative condition.
2.2 anti-drunk pharmacodynamic experiment
Zoopery designs with method 2.1, but makes first administration into, gives wine behind the 20min again, is promptly picked up counting after drinking.Drunk after drinking rate of first experimental evaluation acute alcoholism mice and tolerance time thereof with hold time; The second batch of experimental evaluation acute alcoholism mice ethanol in blood content and SOD enzyme are lived; The 3rd batch of experimental evaluation chronic alcoholism mice alcoholic liver injury situation.
3 medicaments are separated drunk pharmacodynamic experiment result
3.1 acute alcoholism mice pharmacodynamics evaluation result
Drunk after drinking rate of acute alcoholism mice and tolerance time thereof with hold time, ethanol in blood content and the work of SOD enzyme are shown in table 1.
Experimental result shows, with the normal saline matched group relatively, each administration group all demonstrates and significantly separates drunk drug effect, the drunk after drinking rate of mice obviously reduces, drunk before the tolerance time significant prolongation, hold time after drunk and obviously shorten.Separating drunk effect experiment shows; Take in Soboring-up liver-protecting Chinese medical concrete, complex and medicament after drinking and pacify the liquor-saturated celestial being ball that relieves the effect of alcohol and to alleviate drunk effectively and shorten drunk holding time; Can delay ethanol absorption, promote alcohol metabolism, reduce the concentration of ethanol in blood effectively; Can improve SOD enzyme work in the blood effectively, stop the decline of SOD scavenger interior free yl ability, help alleviating ethanol and metabolic intermediate thereof, play the effect of significantly relieving the effect of alcohol the damage of animal body.
Table 1 medicament separate drunk drug effect (the administration after drinking) (n=36 of X ± SD)
Compare *: P＜0.05 through t check and normal saline matched group; *: P＜0.01.
3.2 chronic alcoholism mice alcoholic liver injury situation
Great little with reference to Mus, from gallbladder assist, the LPO value of aspect such as fatty number and mouse liver even slurry is carried out comprehensive test under the enlargement situation of pancreas and liver and the abdomen, experimental result is shown in table 2.
Experimental result shows, the negative control group mice normal raise 28 days after its gallbladder assist, pancreas, the equal no abnormality seen of liver, under its abdomen fat seldom, LH LPO value is lower; Assist after 28 days, pancreas, liver occur that fat deposit is plump under enlargement phenomenon and the abdomen piles up by visible its gallbladder of naked eyes giving continuously wine for the positive controls mice, and the LPO value of LH is higher; Each administration group mice internal organs size appropriateness is not observed abnormal phenomena, and fat is less than the positive controls mice under the interior abdomen of visible each the administration group mice body of naked eyes, and LH LPO is all obviously lower.
Compare with negative control group; Although Medicament for Alcoholism has certain effect for reducing LPO, no matter whether give medicament, long-term a large amount of the absorption under the ethanol condition; The LPO value of mouse liver even slurry all significantly raises, and shows that long-term a large amount of ethanol of taking in will cause alcoholic liver injury.
Compare with positive controls; Each administration group mouse liver even slurry LPO all obviously reduces; Show that Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament all have preferably antioxidation and protect the liver function; Help to improve the removing ability of animal interior free yl, reduce its lipid peroxidation speed, thereby alleviate the alcoholic liver injury that long-term heavy drinking causes.
Experiment shows, long-term a large amount of ethanol of taking in can cause certain damage to the internal organs of animal, makes that gallbladder is assisted, pancreas and liver enlargement; The long-term ethanol of taking in is prone to cause animal shape fat, the phenomenon of athero under the abdomen.Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament have certain effect that alleviates animal internal organs damage after drinking, also have certain sedimentary function of body fat that prevents to cause because of drinking.
The hepatoprotective drug effect of table 2 medicament (the administration after drinking) (n=36 of X ± SD)
Compare *: P＜0.05 through t check and positive controls; *: P＜0.01.
3.3 murine liver tissue section microexamination
The lobules of liver of each experimental mice after fixing, the film-making microexamination, the result is shown in table 3.
Experimental result shows, negative control group Mouse Liver section microexamination no abnormality seen.Positive controls Mouse Liver section microexamination is found, tangible cloudy swelling and hydropic degeneration phenomenon all occur around the nuclear, and the portal area is soaked into, and fat drop is a lot of in the born of the same parents, and the congested and swelling of iuntercellular causes perisinusoidal space to blur or disappearance, and hepatic sinusoid joins together; The central vein edge is loose, and hepatocyte is arranged disorderly and unsystematic, and hepatic cords is fuzzy, and cell boundaries disappears, and the kernel enlargement is loose, and is painted darker, and spotty necrosis and local liver cirrhosis phenomenon appear in hepatocyte.
Compare with positive controls, each administration group lobules of liver hydropic degeneration and cloudy swelling phenomenon are all obviously lighter, and spotty necrosis regulating liver-QI hardening phenomenon does not also appear in hepatocyte; The central vein edge is comparatively tight, and hepatocyte is radial arrangement more, and hepatic cords is clearer basically; The cell boundary is clearer; Kernel is slightly seen enlargement and loose, and is painted deep mixed, and the hepatic sinusoid gap is slightly obvious; Fat drop has also lacked much in the born of the same parents, and lighter away from the local hepatic injury situation of central vein.
Research shows, Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament have the certain protection effect for alleviating the hepatic injury that long-term heavy drinking causes.
Each experimental mice liver slice microexamination n=36 of table 3
The anti-intoxication pharmacodynamic result of 4 medicaments
Drunk after drinking rate of acute alcoholism mice and tolerance time thereof with hold time, ethanol in blood content and the work of SOD enzyme is shown in table 4.
Experimental result shows; Compare with the normal saline matched group, each administration group mice, drunk after drinking rate all has tangible reduction; Blood alcohol content all has in various degree reduction work all has rising in various degree with the SOD enzyme during 90min after drinking, and each administration group all demonstrates tangible anti-intoxication drug effect.
Comparison sheet 3 can find that with table 1 the preceding administration ratio of wine administration mice after drinking more is difficult for the acute alcoholism phenomenon takes place, and more helps the SOD in vivo enhancement enzyme to live, and prevents to cause acute alcoholism because of a large amount of accumulations of interior free yl.
Experiment shows that drink preceding absorption Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament can prevent drunk effectively and shorten the drunk time, play good anti-intoxication effect.The SOD enzyme is lived in situation of change and the blood plasma in each administration group blood, and concentration of alcohol changes and the righting reflex loss situation conforms to, and shows that the work of SOD enzyme can be used as the important indicator of judgement medicament pharmacodynamic feature and animal body self security function.
The anti-drunk drug effect of table 4 medicament (wine before the administration) (n=36 of X ± SD)
1. compare through t check and normal saline matched group
*P＜0.05,
*P＜0.01.
It is visible with anti-intoxication pharmacodynamic experiment result comprehensively to relieve the effect of alcohol; Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament have good relieving the effect of alcohol and anti-intoxication drug effect; Can reduce the concentration of alcohol in the blood effectively; 20min takes in Chinese drugs agentia before and after drinking, the weak point of holding time after low, the drunk preceding tolerance time of the drunk rate of white mice is long and drunk.The preceding absorption of wine Soboring-up liver-protecting Chinese medical concrete of the present invention, complex and medicament have more than absorption after drinking and relieve the effect of alcohol, anti-intoxication and hepatoprotective effect.
Experiment shows that also alcoholism can cause liver to damage, and the correspondingly liver-protective effect of the prescription that sober-up function is strong is also strong more, the drug effect of relieving the effect of alcohol with protect the liver function and have certain dependency.
Under identical recommended intake and identical experiment condition, the relieving the effect of alcohol of the Chinese medicine Soboring-up liver-protecting medicament that the proved recipe that relieves the effect of alcohol of the present invention (being made up of medicinal and edible Chinese medicine materials such as Flos puerariae lobatae, Radix Puerariae, Poria, Fructus Gardeniae, Semen Hoveniae (Fructus Hoveniae), Fructus Ponciri Trifoliatae, Herb Gynostemmae Pentaphylli, Radix Glycyrrhizaes) is processed, anti-intoxication function obviously are superior at present domestic and international like product salable and pacify the liquor-saturated celestial being ball (Japanese SS PHARMACEUTICAL CO (JP) product) that relieves the effect of alcohol.
The present invention has fully used Chinese medical theory, and is novel, and technology is simple, and extraction efficiency is high, and production cost is low, relieves the effect of alcohol, anti-intoxication and the hepatoprotective drug effect is obvious, has bigger dissemination.
Claims (6)
1. the method for preparing of a Chinese medicine Soboring-up liver-protecting medicament, it is characterized in that: each composition weight proportioning of Chinese medicine Soboring-up liver-protecting medicament is Flos puerariae lobatae 6～50%, Semen Hoveniae (Fructus Hoveniae) 6～40%, Herb Gynostemmae Pentaphylli 1～18%, Fructus Ponciri Trifoliatae 1～18%, Radix Glycyrrhizae 1～18%, Fructus Gardeniae 1～18%, Radix Puerariae 3～18%, Poria 3～18%; At first be to coarse powder with Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae and Fructus Gardeniae pulverize separately; The final concentration that adds 9～15 times of medical material amount W/W is that 30%～70% polar organic solvent aqueous solution extracts; Merge extractive liquid; Filter, decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete; In the described Chinese medical concrete method for preparing: under 50 ℃～80 ℃ conditions, extract 1～3 time each 1～3 hour after adding the polar organic solvent aqueous solution; Again Radix Puerariae, Poria pulverize separately are become fine powder, add mixing in the above-mentioned Chinese medical concrete, drying is processed, and said polar organic solvent is one or more mixed solvents in methanol, ethanol or the acetone.
2. the method for preparing of Chinese medicine Soboring-up liver-protecting medicament according to claim 1 is characterized in that: said drying mode is spray drying, lyophilization, pneumatic conveying drying, microwave drying or vacuum drying.
3. the method for preparing of Chinese medicine Soboring-up liver-protecting medicament according to claim 2 is characterized in that: can Chinese medical concrete be processed capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill.
4. the method for preparing of a Chinese medicine Soboring-up liver-protecting medicament, it is characterized in that: each composition weight proportioning of Chinese medicine Soboring-up liver-protecting medicament is Flos puerariae lobatae 25～40%, Semen Hoveniae (Fructus Hoveniae) 15～30%, Herb Gynostemmae Pentaphylli 3～10%, Fructus Ponciri Trifoliatae 3～10%, Radix Glycyrrhizae 3～10%, Fructus Gardeniae 3～10%, Radix Puerariae 6～10%, Poria 6～10%; At first be to coarse powder with Flos puerariae lobatae, Semen Hoveniae (Fructus Hoveniae), Herb Gynostemmae Pentaphylli, Fructus Ponciri Trifoliatae, Radix Glycyrrhizae and Fructus Gardeniae pulverize separately; The final concentration that adds 9～15 times of medical material amount W/W is that 30%～70% polar organic solvent aqueous solution extracts; Merge extractive liquid; Filter, decompression and solvent recovery is condensed into the Soboring-up liver-protecting Chinese medical concrete; In the described Chinese medical concrete method for preparing: under 50 ℃～80 ℃ conditions, extract 1～3 time each 1～3 hour after adding the polar organic solvent aqueous solution; Again Radix Puerariae, Poria pulverize separately are become fine powder, add mixing in the above-mentioned Chinese medical concrete, drying is processed, and said polar organic solvent is one or more mixed solvents in methanol, ethanol or the acetone.
5. the method for preparing of Chinese medicine Soboring-up liver-protecting medicament according to claim 4 is characterized in that: said drying mode is spray drying, lyophilization, pneumatic conveying drying, microwave drying or vacuum drying.
6. the method for preparing of Chinese medicine Soboring-up liver-protecting medicament according to claim 5 is characterized in that: can Chinese medical concrete be processed capsule, granule, tablet, oral liquid, syrup, microcapsule, powder, drop pill or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101773390A CN101816723B (en) | 2006-09-15 | 2006-09-15 | Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101773390A CN101816723B (en) | 2006-09-15 | 2006-09-15 | Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2006100688479A Division CN1931270B (en) | 2006-09-15 | 2006-09-15 | Sobering up and liver protecting Chinese medicine preparation and its preparation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101816723A CN101816723A (en) | 2010-09-01 |
| CN101816723B true CN101816723B (en) | 2012-04-18 |
Family
ID=42652100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101773390A Expired - Fee Related CN101816723B (en) | 2006-09-15 | 2006-09-15 | Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816723B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101797045B (en) * | 2010-04-01 | 2013-09-25 | 河北农业大学 | Honey raisin tree oral liquid and processing method thereof |
| CN103181597B (en) * | 2012-09-25 | 2014-10-29 | 许金禄 | Ledum palustre detoxication health care liquid and preparation method thereof |
| CN103860628B (en) * | 2012-12-14 | 2015-08-12 | 湖北老龙洞杜仲开发有限公司 | A kind of Dealcoholic sobering-up Chinese patent medicine preparation and preparation method thereof |
| CN103330799A (en) * | 2013-07-19 | 2013-10-02 | 苏州市天灵中药饮片有限公司 | Traditional Chinese medicine electuary for temperance |
| CN105580899A (en) * | 2014-11-15 | 2016-05-18 | 柳易程 | Alcoholism-relieving traditional Chinese medicine yogurt and preparation method thereof |
| CN110419608A (en) * | 2019-07-31 | 2019-11-08 | 广东咕咚生物科技有限公司 | A kind of compound health preserving tea |
| CN111296702A (en) * | 2020-03-24 | 2020-06-19 | 孙丽丽 | Health beverage with functions of relieving alcoholism and protecting liver |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100340281C (en) * | 2005-01-10 | 2007-10-03 | 于吉善 | Sobering up infusion granule and preparation thereof |
-
2006
- 2006-09-15 CN CN2010101773390A patent/CN101816723B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100340281C (en) * | 2005-01-10 | 2007-10-03 | 于吉善 | Sobering up infusion granule and preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101816723A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1931270B (en) | Sobering up and liver protecting Chinese medicine preparation and its preparation process | |
| JP5184090B2 (en) | Pharmaceutical composition for treating and / or preventing hyperlipidemia, its production method and its use | |
| CN101816723B (en) | Sobering up and liver protecting Chinese medicinal preparation and preparation method thereof | |
| CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
| JP6605036B2 (en) | Method for preparing a medicinal composition for preventing or treating liver and kidney damage-related diseases | |
| CN105030984B (en) | A kind of semen litchi health care oral liquid and preparation method with hypoglycemic, tune rouge and alleviation diabetic complication | |
| CN103689708B (en) | Pine pollen-fragrant solomonseal rhizome liquid beverage | |
| CN104688933B (en) | Composition of Pu' er tea effective components and application thereof in preparing hypoglycemic drug or health food | |
| CN100444849C (en) | New use of tribulus terrestris extraction | |
| CN104771595B (en) | A kind of Chinese medicine composition of strengthen immunity and preparation method thereof | |
| CN101744993B (en) | Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof | |
| CN102641342A (en) | Traditional Chinese medicine extract for treating nephropathy and preparation method | |
| CN103285072B (en) | Comprise extract and the medical usage thereof of hyperin | |
| CN105943681A (en) | Semen litchi steroid saponin extract having function of improving insulin resistance | |
| CN102652791B (en) | Medicinal composition with hepatic fibrosis resistance and preparation method | |
| CN101745011B (en) | Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof | |
| CN100528170C (en) | Mangiferin preparation and production thereof | |
| CN101744991B (en) | Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN103705768A (en) | Composition for preventing alcoholic liver disease and application thereof | |
| CN104069312B (en) | Treat Chinese medicine composition of apoplexy and preparation method thereof, pharmaceutical preparation and application | |
| CN107582880A (en) | A kind of bamboo shoot flavonoid composition and its slow-release solid beverage with hypoglycemic effect | |
| CN101744987B (en) | Single extraction method of ginseng, ophiopogon root and shiandra and preparation thereof | |
| CN104688934A (en) | Composition of Pu'er tea effective component and application of composition in preparation of medicine or health food for reducing fat | |
| CN105709008A (en) | Traditional Chinese medicine composition for treatment of gout and preparation method thereof | |
| CN102133277B (en) | Red paeony root active constituent as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20140915 |
|
| EXPY | Termination of patent right or utility model |